Thailand to extend dose gap for AstraZeneca vaccine to 16 weeks


  • World
  • Monday, 24 May 2021

FILE PHOTO: A medical worker holds a bottle of AstraZeneca's COVID-19 vaccine at a vaccination centre in Kuala Lumpur, Malaysia May 5, 2021. REUTERS/Lim Huey Teng/File Photo

BANGKOK (Reuters) - Thailand will extend the gap between the first and second doses of AstraZeneca's COVID-19 vaccine to 16 weeks, in an effort to inoculate more people faster, a senior health official said on Monday.

The plan follows a similar decision by Spain to stretch the gap between two AstraZeneca doses to 16 weeks, which is beyond the 12 weeks maximum interval approved by the European Medicines Agency. A 16-week interval has not been tested in human trials.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

This AI-focused chip is powered by light
Study warns users about health information on TikTok
Canada's British Columbia calls off drug decriminalization pilot project
3 killed after building collapses in north Nigeria
Aerosmith frontman Steven Tyler wins dismissal for good of sexual assault lawsuit
Chinese company to build photovoltaic factory in Saudi port
Nearly 23 pct of Canadian population reported food insecurity in 2022
Canada announces investment to grow semiconductor supply chain
U.S. stocks close higher
Feature: Chinese firms eager to showcase new products at Spain seafood fair

Others Also Read